Results
1 -
10 of
24
(Click
here to explore results)
- Drug Discovery from Natural Products, Chapter 16 Epothilones as Lead Structures for New Anticancer Drugs. Bernhard Pfeiffer, Fabienne Zdenka Gaugaz, Raphael Schiess, Karl-Heinz Altmann*
, 2012
, Pages 339-373
- Macrocycles in Drug Discovery, CHAPTER 3 Epothilones. Raphael Schiess, Karl-Heinz Altmann
, 2015
, Pages 78-108
- The Handbook of Medicinal Chemistry: Principles and Practice, CHAPTER 27 Lessons Learned From the Discovery and Development of Lapatinib/Tykerb. G. Stuart Cockerill, Karen E. Lackey
, 2015
, Pages 676-698
- DNA Damage, DNA Repair and Disease: Volume 2, Chapter 26 Evolving DNA Repair Targets for Cancer Therapy. M. T. Sadiq, S. Madhusudan
, 2021
, Volume 2
, Pages 254-285
- Biocatalysis: An Industrial Perspective, CHAPTER 5 Bristol-Myers Squibb: Preparation of Chiral Intermediates for the Development of Drugs and APIs. Ramesh N. Patel
, 2018
, Pages 125-167
- Nanomedicines: Design, Delivery and Detection, Chapter 8 Polymeric Nanoparticles and Cancer: Lessons Learnt from CRLX101. Ismael Gritli, Edward Garmey, Scott Eliasof, Andres Tellez, Mark E. Davis, Yen Yun
, 2016
, Pages 199-232
- Specialised Pharmaceutical Formulation: The Science and Technology of Dosage Forms, Chapter 10 Development Programs for Oral Fixed Dose Combination Products. Patrick J. Crowley, Sharon M. Maglennon, Luigi G. Martini, David Templeton
, 2022
, Pages 259-286
- NMR-based Metabolomics, CHAPTER 4 NMR Spectroscopy of Serum and Plasma. Hector C. Keun
, 2018
, Pages 85-132
- Inhibitors of Molecular Chaperones as Therapeutic Agents, CHAPTER 13 Hsp90 Inhibitors in Clinic. Emin Avsar
, 2014
, Pages 336-378
- Metabolism, Pharmacokinetics and Toxicity of Functional Groups: Impact of Chemical Building Blocks on ADMET, Chapter 9 Pharmacokinetics and Metabolism of Compounds that Mimic Enzyme Transition States. Iain Gardner, Chris Barber, Martin Howard, Aarti Sawant, Kenny Watson
, 2010
, Pages 390-459